These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 2646863)

  • 21. [Antinuclear factors. Demonstration and clinico-diagnostic significance].
    Maas D
    Med Klin; 1969 Jul; 64(29):1302-7. PubMed ID: 4184549
    [No Abstract]   [Full Text] [Related]  

  • 22. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Lee H; Kim Y; Han K; Oh EJ
    Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of antibodies against nuclear antigens as determined by immunoblotting.
    de Rooij DJ; Habets WJ; Stapel S; van de Putte LB; van Venrooij WJ
    Scand J Rheumatol Suppl; 1985; 56():93-7. PubMed ID: 3890157
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunological diagnosis of connective tissue diseases (author's transl)].
    Helmke K
    Immun Infekt; 1981 Nov; 9(6):213-22. PubMed ID: 6978279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
    Mahler M; Fritzler MJ; Blüthner M
    Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The autoimmune diseases.
    Kohler PF; Vaughan J
    JAMA; 1982 Nov; 248(20):2646-57. PubMed ID: 7143627
    [No Abstract]   [Full Text] [Related]  

  • 29. So you suspect mixed connective tissue disease (MCTD). Which tests to perform?
    Gladman DD; Urowitz MB
    Int J Dermatol; 1984; 23(6):392-3. PubMed ID: 6384083
    [No Abstract]   [Full Text] [Related]  

  • 30. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against Ku protein in sera from patients with autoimmune diseases.
    Yaneva M; Arnett FC
    Clin Exp Immunol; 1989 Jun; 76(3):366-72. PubMed ID: 2665976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinuclear and anticytoplasmic antibodies. Concepts and misconceptions.
    Sontheimer RD; Deng JS; Gilliam JN
    J Am Acad Dermatol; 1983 Sep; 9(3):335-43. PubMed ID: 6415131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
    Hietarinta M; Lassila O
    Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed connective tissue disease.
    Brook AS
    Aust N Z J Med; 1978; 8 Suppl 1():130-3. PubMed ID: 310295
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.
    Feist E; Brychcy M; Hausdorf G; Hoyer B; Egerer K; Dörner T; Kuckelkorn U; Burmester GR
    Ann Rheum Dis; 2007 Jan; 66(1):5-11. PubMed ID: 16815863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antinuclear antibodies].
    Goulvestre C
    Presse Med; 2006 Feb; 35(2 Pt 2):287-95. PubMed ID: 16493331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen-vascular diseases.
    Rothschild B
    Prim Care; 1984 Jun; 11(2):307-23. PubMed ID: 6566363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The autoimmune diseases.
    Condemi JJ
    JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.